Clinical trials
Phase 3 Pancreatic Neoplasms trials in Greece
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2019 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 2 |
| AB Science | 1 |
| Amgen | 1 |
| Eli Lilly and Company | 1 |
| Michalis Karamouzis | 1 |
| NCIC Clinical Trials Group | 1 |
| NantCell, Inc. | 1 |
| OSI Pharmaceuticals | 1 |
| Royal Liverpool University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 10 |
| Neoplasm Metastasis | 3 |
| Neoplasms | 2 |
| Colorectal Neoplasms | 1 |
| Endocrine Gland Neoplasms | 1 |
| Gastrointestinal Neoplasms | 1 |
| Jaundice | 1 |
| Thromboembolism | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.